Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
21.89
-0.48 (-2.15%)
At close: Sep 11, 2026

SHA:688443 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
526.721,5382,0352,89249.2814.15
Trading Asset Securities
1,332681.23412.5827.71237.36427.11
Cash & Short-Term Investments
1,8582,2192,4482,920286.64441.25
Cash Growth
-22.26%-9.36%-16.16%918.65%-35.04%684.19%
Accounts Receivable
86.5921.0812.01---
Other Receivables
2.910.061.380-1.53
Receivables
89.521.1413.380-1.53
Inventory
140.4696.1250.1555.4556.3333.66
Other Current Assets
106.14107.08110.5956.5656.0352.76
Total Current Assets
2,1942,4432,6223,032399529.2
Property, Plant & Equipment
471.33482.76441.55487.82487.75327.83
Other Intangible Assets
45.442.6943.5943.5445.0845.92
Long-Term Deferred Charges
20.920.1725.1627.9225.5123.51
Other Long-Term Assets
7.074.4113.263.464.7776.36
Total Assets
2,7392,9933,1463,595962.111,003

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
84.1895.4367.0683.0467.8446.61
Accrued Expenses
62.4287.363.0337.7429.7124.29
Short-Term Debt
100.06--0.63--
Current Portion of Long-Term Debt
85.1158.8126.24-5.30.9
Current Portion of Leases
-11.0712.1310.077.646.51
Current Unearned Revenue
46.74114.52----
Other Current Liabilities
22.715.595.825.415.877.7
Total Current Liabilities
402.47472.72174.29136.87126.3786.01
Long-Term Debt
942.65884.82786.13608.48738.59535.55
Long-Term Leases
5.357.9812.6321.8230.3728.65
Long-Term Unearned Revenue
39.3243.0446.6243.237.6935.55
Other Long-Term Liabilities
67.78----5.08
Total Liabilities
1,4581,4091,020810.36933.03690.84

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
366.68366.68366.68366.68275275
Additional Paid-In Capital
4,2054,1924,1924,038573.29279.82
Retained Earnings
-3,270-2,953-2,418-1,621-819.21-242.84
Treasury Stock
-20.3-20.3-14.67---
Shareholders' Equity
1,2821,5852,1262,78429.08311.98
Total Liabilities & Equity
2,7392,9933,1463,595962.111,003

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,1331,063837.13640.99781.91571.6
Net Cash (Debt)
725.161,1561,6112,279-495.27-130.35
Net Cash Growth
-49.37%-28.22%-29.31%---
Net Cash Per Share
1.973.154.387.11-1.80-0.47
Filing Date Shares Outstanding
370.86366.68366.68366.68275275
Total Common Shares Outstanding
370.86366.68366.68366.68275275
Working Capital
1,7921,9712,4482,895272.63443.19
Book Value Per Share
3.464.325.807.590.111.13
Tangible Book Value
1,2361,5422,0822,741-15.99266.06
Tangible Book Value Per Share
3.334.215.687.47-0.060.97
Buildings
-115.11115.03114.98105.8999.77
Machinery
-529.02516.53457.63302.65261.93
Construction In Progress
-94.416.7452.18164.8218.27